Skip to main content
. 2022 Jul 4;12:865292. doi: 10.3389/fonc.2022.865292

Figure 4.

Figure 4

Kaplan-Meier curves of real-world progression-free survival and overall survival in patients with liver metastasis. Analysis of rwPFS (A) and OS (B) adjusted for demographic and clinical variables; number of patients at risk are shown. LET, letrozole; OS, overall survival; PAL, palbociclib; rwPFS, real-world progression-free survival. *Hazard ratios were estimated by multivariate Cox regression models adjusted for baseline demographic and clinical variables.